Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongfeng Zeng

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|June 20, 2025
Case Report: Combined umbilical cord blood and peripheral blood stem cell transplantation with donor lymphocyte infusion for R/R AML post CAR-CLL1 failureFanqiao Meng, Yu Liu, Dongfeng Zeng
Annals of Laboratory Medicine|December 22, 2022
The First Case Report of <i>JAK2-BCR-PPP1R32</i> Fusion Genes Because of a Translocation (9;22;11)(p24;q11.2;q13) in a Patient With Myeloproliferative NeoplasmHuan Xie, Zhongyue Zhao, Dongfeng Zeng
Pediatric Blood & Cancer|March 18, 2025
Venetoclax Plus Daratumumab Bridging Allo-HSCT in Early T-Cell Precursor Acute Lymphoblastic LeukemiaFanqiao Meng, Yu Liu, Dongfeng Zeng
Annals of Hematology|March 13, 2025
TIGIT/PVR axis regulates anti-tumor immunity in hematologic malignanciesFanqiao Meng, Maoyuan Xiang, Yu Liu, et al.
BMC Cancer|January 13, 2025
Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysisFanqiao Meng, Maoyuan Xiang, Yu Liu, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 2, 2008
Association between MYOC.mt1 promoter polymorphism and risk of primary open-angle glaucoma: a systematic review and meta-analysisTing Liu, Dongfeng Zeng, Changqing Zeng, et al.
Inflammatory Bowel Diseases|March 21, 2020
Letter to the Editor: Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based StudyHuan Xie, Dongfeng Zeng, Dongfeng Chen, et al.
The Oncologist|June 14, 2018
Frontline Treatment for Older Patients with Mantle Cell LymphomaHaige Ye, Aakash Desai, Dongfeng Zeng, et al.
Oncotarget|November 19, 2016
Magic year for multiple myeloma therapeutics: Key takeaways from the ASH 2015 annual meetingKejie Zhang, Aakash Desai, Dongfeng Zeng, et al.
Peerj|December 10, 2025
Retrospective study on the clinical outcomes and characteristics of acute myeloid leukemia: different outcomes in the same risk groupFanqiao Meng, Maoyuan Xiang, Huan Xie, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|June 20, 2025
Case Report: Combined umbilical cord blood and peripheral blood stem cell transplantation with donor lymphocyte infusion for R/R AML post CAR-CLL1 failureFanqiao Meng, Yu Liu, Dongfeng Zeng
Annals of Laboratory Medicine|December 22, 2022
The First Case Report of <i>JAK2-BCR-PPP1R32</i> Fusion Genes Because of a Translocation (9;22;11)(p24;q11.2;q13) in a Patient With Myeloproliferative NeoplasmHuan Xie, Zhongyue Zhao, Dongfeng Zeng
Pediatric Blood & Cancer|March 18, 2025
Venetoclax Plus Daratumumab Bridging Allo-HSCT in Early T-Cell Precursor Acute Lymphoblastic LeukemiaFanqiao Meng, Yu Liu, Dongfeng Zeng
Annals of Hematology|March 13, 2025
TIGIT/PVR axis regulates anti-tumor immunity in hematologic malignanciesFanqiao Meng, Maoyuan Xiang, Yu Liu, et al.
BMC Cancer|January 13, 2025
Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysisFanqiao Meng, Maoyuan Xiang, Yu Liu, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 2, 2008
Association between MYOC.mt1 promoter polymorphism and risk of primary open-angle glaucoma: a systematic review and meta-analysisTing Liu, Dongfeng Zeng, Changqing Zeng, et al.
Inflammatory Bowel Diseases|March 21, 2020
Letter to the Editor: Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based StudyHuan Xie, Dongfeng Zeng, Dongfeng Chen, et al.
The Oncologist|June 14, 2018
Frontline Treatment for Older Patients with Mantle Cell LymphomaHaige Ye, Aakash Desai, Dongfeng Zeng, et al.
Oncotarget|November 19, 2016
Magic year for multiple myeloma therapeutics: Key takeaways from the ASH 2015 annual meetingKejie Zhang, Aakash Desai, Dongfeng Zeng, et al.
Peerj|December 10, 2025
Retrospective study on the clinical outcomes and characteristics of acute myeloid leukemia: different outcomes in the same risk groupFanqiao Meng, Maoyuan Xiang, Huan Xie, et al.
Pageof 5